Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Feb 3.
Published in final edited form as: Nature. 2008 Jan 24;451(7177):417–424. doi: 10.1038/nature06485

Catalytic C–H Functionalization by Metal Carbenoid and Nitrenoid Insertion

Huw M L Davies 1,*, James R Manning 1
PMCID: PMC3033428  NIHMSID: NIHMS183697  PMID: 18216847

Abstract

Selective methods for C–H functionalization are of intense current interest because they offer new strategic approaches for synthesis. A very promising C–H functionalization method is the insertion of metal carbenes and nitrenes into C–H bonds. This chemistry has experienced considerable growth in the last decade, particularly in the area of enantioselective intermolecular reactions. This review will bring together the major aspects of this C–H functionalization chemistry and provide a useful perspective on how this methodology can impact the synthesis and accessibility of natural products and pharmaceutical targets.

Introduction

In 2006, 31 new chemical entities were introduced to the world pharmaceutical market and 2,075 molecules were in Phase I/II clinical development.1 The majority of these were small-molecule (molecular weight <1000) organic compounds.2 As knowledge about the specific interactions of drugs in-vivo increases, often so does the structural complexity of new drug targets. A major obstacle to the development of such drugs is the difficulty associated with synthesizing large quantities in an economical fashion, as complex multi-step syntheses are usually required. In the general media, it is often overlooked that the accessibility of the components required for these new treatments will often govern their eventual success or failure. Likewise, a design element of any pharmaceutical agent is the expectation that the target compounds can be made economically. Therefore, new strategies for synthesis can become enabling technologies, opening up new vistas of targets and materials that would have been previously out of range. For example, new methodologies such as metal catalyzed cross-coupling3 and olefin metathesis4–6 have rapidly become central transformations in the synthesis of new pharmaceutical agents. Selective C–H functionalization is a class of reactions that could lead to a paradigm shift in organic synthesis, relying on selective modification of ubiquitous C–H bonds of organic compounds instead of the standard approach of conducting transformations on pre-existing functional groups. The reactive sites in each type of transformation are very different, as illustrated in Figure 1.

Figure 1. Synthesis by functional group modification compared to C–H functionalization.

Figure 1

Traditional sites for modification of organic molecules (blue) rely on reactive (polarizable) functional groups. Such modes of reactivity include oxidation/reduction, aromatic substitution, and nucleophilic/electrophilic attack. Sites for direct functionalization of C–H bonds (red) often have adjacent “activating” groups, but also can occur at isolated positions.

Due to the many opportunities associated with C–H functionalization, this field has become an active area of research. Organometallic chemists have focused much attention on developing “C–H activation” strategies, whereby a highly reactive metal complex inserts into a C–H bond, activating the system for subsequent transformations.7–9 One of the major challenges associated with this chemistry has been to render it catalytic in the metal complex.10 A partial solution to this problem has been to use neighboring functionality to direct less reactive metal complexes to the site for functionalization. Numerous reviews have been written about this method for C–H functionalization.11–17 This review, however, will highlight an alternative approach, in which a divalent carbon (carbene)18 or a monovalent nitrogen (nitrene),19 coordinated to a metal complex, inserts into a C–H bond.20 This alternative approach offers many advantages over the metal-induced C–H insertion because the reactions exhibit high turnover numbers and can lead to high levels of selectivity, both in terms of regioselectivity and stereoselectivity (Figure 2).

Figure 2. Metal carbenoid C–H functionalization versus the “traditional” C–H activation.

Figure 2

In a traditional C–H activation manifold, the highly reactive metal complex inserts into a C–H bond. Regeneration of the active metal complex to form the C–H activation product has proven difficult. In contrast, C–H functionalization via a metal carbenoid approach typically utilizes a high-energy diazo compound and loss of nitrogen provides the driving force for the energetically unfavorable formation of the carbenoid. The highly reactive carbenoid species then inserts into a C–H bond to form the C–H activation product and liberates the metal catalyst for another cycle.

C–H Functionalization by Metal Carbenoids

The standard method for generating the transient metal carbenes is by metal-induced extrusion of nitrogen from diazo compounds.21 On account of the challenges of regioselectivity associated with the carbene-induced C–H functionalization, most of the early advances in this field were achieved in systems capable of intramolecular reactions.21–23 Because the rhodium carbenoid and the reacting C–H bond are connected by a suitable tether, they are brought into close proximity, leading to a favorable regioselective transformation. By using a chiral catalyst, the C–H insertion can be made enantioselective, favoring the formation of one mirror image of the product over the other. This type of approach has been used in the synthesis of various pharmaceutical agents, such as (R)-(−)-baclofen24 (3) and (R)-(−)-rolipram25 (6) (Figure 3).

Figure 3. Intramolecular C–H insertions.

Figure 3

a) The intramolecular C–H insertion of an acceptor substituted carbenoid catalyzed by the chiral rhodium carboxamidate catalyst Rh2(4S-MPPIM)4 is the key step in an enantioselective synthesis of the GABAB receptor agonist (R)-(−)-baclofen (ref 24). b) The intramolecular C–H insertion of an acceptor/acceptor-substituted carbenoid catalyzed by the chiral rhodium carboxylate catalyst Rh2(S-BPTTL)4 results in a concise synthesis of the phosphodiesterase type IV inhibitor (R-)(−)rolipram (ref 25).

In terms of strategic reactions, controllable intermolecular transformations would be much more powerful because the sequence of steps required to make the substrate for an intramolecular reaction would no longer be needed. Controlling the regioselectivity of intermolecular C–H insertions, however, has been challenging, particularly in the case of the most commonly used metal carbenoids derived from acceptor-only substituted diazoacetates.22, 26 The metal carbenoids behave as very electrophilic species and the electron-withdrawing ester group reinforces the high reactivity, generating a system characterized by poor regioselectivity between different C–H bonds.27–29 In recent years, extensive efforts have been made to attenuate the carbenoid reactivity by altering the nature of the catalysts with some improvements having been made by using very bulky ligands with copper30 and silver31 complexes. The major breakthrough in this field, however, was the discovery that carbenoids functionalized with both donor and acceptor groups were much more chemoselective than the traditional carbenoids as shown in Figure 4.18, 32, 33

Figure 4. Controlling factors of carbenoid reactivity.

Figure 4

The substituents attached to the carbenoid help to modulate its reactivity. The presence of both an electron-donating group and an electron-withdrawing group is necessary to reduce carbene dimerization pathways and increase selectivity for intermolecular reactions. During the C–H activation event, a partial positive charge buildup occurs at the carbon undergoing C–H functionalization. Sites adjacent to functionality that can stabilize this polarization are considered to be electronically “activated” toward carbenoid reactions.

The synthetic potential of the donor/acceptor carbenoids is illustrated in a direct enantioselective synthesis of the most active enantiomer of threo-methylphenidate (Ritalin) (9). Ritalin is an important drug for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and, as an old drug, is sold as a racemate. The most active enantiomer of Ritalin has been marketed as an independent therapeutic agent.34 Its synthesis using conventional functional group manipulations requires multiple steps.35, 36 The C–H functionalization approach to Ritalin, conversely, is direct.37, 38 The Rh2(S-biDOSP)239 catalyzed reaction of N-protected piperidine (7) with methyl phenyldiazoacetate (8) followed by removal of the protecting group leads to the rapid synthesis of (R,R')-(+)-methylphenidate (9) in 86% ee (Figure 5).38

Figure 5. Ritalin synthesis.

Figure 5

A concise, stereoselective synthesis of the biologically active enantiomer of the pharmaceutical agent Ritalin (threo-methylphenidate) was achieved using the bridged, chiral rhodium catalyst Rh2(S-biDOSP)2 (ref 38).

C–H Functionalization can provide complementary approaches to achieve transformations equivalent to some of the classic reactions of organic synthesis.40–45 For example, C–H functionalization adjacent to oxygen can lead to products that would be commonly derived from an aldol reaction (Figure 6).44, 46 In the specific example used to illustrate this concept, other key elements that control the selectivity of this chemistry are demonstrated. The carbenoid has an electronic preference to functionalize C–H bonds in which the carbon can stabilize positive charge build-up because the C–H insertion has the partial characteristic of a hydride abstraction event.47, 48 In this case, selective functionalization occurs adjacent to the siloxy group rather than the more electron-withdrawing acetoxy group in compound 10. Additionally, if there is good steric differentiation at the C–H insertion site, high levels of diastereoselectivity can be achieved. Thus, 11 is formed in 88% yield, >94% de and 82% ee.44

Figure 6. C–H functionalization as a strategic reaction.

Figure 6

a) C–H insertion α to oxygen generates products that would classically be formed via an aldol reaction. The insertion occurs preferentially at the site adjacent to the more electron-rich siloxy-protected oxygen (ref 44) b) C–H insertion a to nitrogen generates the products formally derived from a Mannich reaction, with high levels of enantiocontrol (ref 42).

C–H Functinalization adjacent to nitrogen can lead to products that would be typically formed from a Mannich reaction, as illustrated in the direct synthesis of β-amino ester 13.42 This example illustrates the important controlling influences in steric factors, because the electronically most activated site in compound 12, the benzylic carbon, is sterically inaccessible and selective functionalization occurs at the N-methyl group.42, 49, 50

A further advantage of the carbenoid-induced C–H functionalization is the possibility for the C–H insertion step to initiate a cascade sequence. A spectacular example of such an event is termed the combined C–H activation/Cope rearrangement.51–56 One of the earliest examples of this reaction is shown between the vinyldiazoacetate 15 and 1,3-cyclohexadiene in Figure 7. Before the C–H functionalization is complete a rearrangement occurs to form a 1,4-cyclohexadiene derivative 16 with exceptional enantiocontrol. The entire process is believed to occur via a concerted, ordered transition state that leads to higher stereoselectivity than is normally observed in a direct C–H insertion. This transformation has been used in a very concise enantioselective formal synthesis of the antidepressant sertraline (Zoloft, Figure 7).51

Figure 7. Combined C–H activation/Cope rearrangement.

Figure 7

The C–H functionalization with a vinyldiazoacetate begins at the allylic C–H bond, but is interrupted when a Cope rearrangement occurs (see blue intermediate) to give the “combined C–H activation/Cope rearrangement” product with exceptionally high enantioselectivity (ref 51).

An even more elaborate sequence of events has been developed for the enantioselective synthesis of 4-substituted indoles. Indoles are present in a number of pharmaceutical agents57 and there has been much interest in the enantioselective synthesis of 1-aryl-1-indolylalkyl derivatives. Normally the indole is functionalized at the 2- or 3-position because these are the most reactive sites using conventional chemistry.58–60 In contrast, the C–H functionalization strategy results in a very efficient method for generating 4-substituted indoles with high enantioselectivity (Figure 8).56 These types of compounds and related structures have not been extensively studied as potential therapeutic agents, presumably because they were not readily accessible.

Figure 8. Tris-indole synthesis.

Figure 8

The product of the combined C–H activation/Cope rearrangement between the vinyldiazoacetate 18 and the 4-acetoxy-6,7-dihydroindole 19 undergoes loss of acetic acid to generate the aromatized tris-indole compound 20 in good yield and in high enantiomeric excess (ref 56).

A powerful enabling synthetic methodology should greatly simplify the total synthesis of complex natural products. Notable examples of this have been illustrated in the synthesis of the natural products derived from the West Indian gorgonian coral pseudopterogorgia elisabethae (Figure 9).61 Previous syntheses have struggled with controlling the stereochemistry at the three stereocenters indicated in red, primarily because the natural products lack suitable functional groups as handles in the synthetic transformations.62–67 In contrast, an enantiodivergent C–H functionalization of racemic dihydronaphthalenes 21 generates the core structures 23 with high stereoselectivity at all three stereocenters. In the presence of the chiral catalyst Rh2(S-DOSP)4,68 the other enantiomer of the dihydronaphthalene 21 reacts in an entirely different manner to form cyclopropanation products.69 This reaction can be conducted with a variety of dihydronaphthalene derivatives and has been applied to very efficient syntheses of a range of natural products including elisapterosin B70 (24), colombiasin A70 (25), elisabethadione71 (26), the p-benzoquinone 2771 and erogorgiaene (28).69

Figure 9. Application of C–H functionalization to natural product synthesis.

Figure 9

A series of diterpene natural products have been isolated from the gorgonian coral pseudopterogorgia elisabethae. All are derived biosynthetically from (+)-elisabethatriene and share the same configuration at the three stereocenters shown in red (ref 61). One of the most challenging aspects in synthesizing these molecules is controlling the stereochemistry at these sites because of the lack of neighboring functional groups. A powerful feature of the combined C–H activation/Cope rearrangement is the ability of the chiral catalyst Rh2(R-DOSP)4 to differentiate between the enantiomers of a racemic substrate to generate all three stereocenters in a single step.

C–H Functionalization by Metal Nitrenoids

In recent years, metal nitrenoid complexes have also been shown to be capable reagents for C–H functionalization, a reaction that is usually called C–H amination.14, 72, 73 Some spectacular intramolecular examples have been reported by Du Bois for the synthesis of complex natural products such as manzacidin A74 (32), (+)-saxitoxin75 (35) and (−)-tetrodotoxin76 (40) (Figure 10). These transformations illustrate how by judicious choice of substrates, the C–H amination can be conducted in the presence of a range of functional groups. Generally, the most broadly used precursors to the transient metal nitrenes have been aryliminoiodinanes, which are decomposed by a suitable metal complex.77 In the syntheses described herein, the aryliminoiodinanes are produced in-situ from the corresponding amine, which makes the overall transformations even more attractive.78, 79

Figure 10. Application of C–H amination to natural product synthesis.

Figure 10

a–b) Sulfamate esters provide excellent precursors to nitrenes that can undergo highly diastereoselective intramolecular insertions into tertiary C–H bonds. Du Bois has shown the potential of this methodology with syntheses of the marine alkaloid manzacidin A (ref 74) and the natural product (+)-saxitoxin, an ion channel blocker (ref 75). c) An elegant synthesis of the potent marine poison (±)-tetrodotoxin by Du Bois illustrates the utility and complementarity of C–H functionalization by metal carbenoids and nitrenoids (ref 76).

Lebel has shown that N-tosyloxyamides such as 41 are also efficient precursors to transient metal nitrenoids.80, 81 By conducting this nitrene insertion with chiral dirhodium catalyst Rh2(S-TCPTAD)4, enantioselective transformations can be achieved as illustrated in Figure 11.82 The site for C–H amination is governed by the length of the tether and in general five-membered rings are preferred.

Figure 11. Enantioselective C–H amination.

Figure 11

Lebel has developed an alternative method for the in-situ generation of metal nitrenoids using N-tosyloxycarbamates as the precursor. This method avoids the generation of a stoichiometric amount of iodobenzene, a drawback to the use of hypervalent iodine reagents which are commonly used to generate nitrene precursors in-situ. Lebel's method proceeds with high efficiency (ref 80), and when the chiral catalyst Rh2(S-TCPTAD)4 is used, good levels of enantioselectivity can be achieved (ref 82).

Du Bois has developed a bridged achiral rhodium catalyst Rh2(esp)2 that has performed well at low catalyst loadings in both intra- and inter-molecular C–H amination reactions (Figure 12).83–85 Enantioselective intermolecular reactions of metal nitrenes are less developed than the parallel reaction of metal carbenes, although some significant examples have been reported.81, 82, 86, 87 A conceptually interesting approach to stereoselective intermolecular nitrene chemistry involves the use of a chiral sulfonamide 48 as the amine source in the reactions. Exceptionally high diastereoselectivity can be obtained in matched reactions between the appropriate enantiomers of a chiral sulfonamide and a chiral rhodium catalyst.87 Given the ubiquity of nitrogen atoms in biologically active compounds, C–H amination as an enabling technology in pharmaceutical synthesis has broad potential. A concise, highly enantioselective synthesis of the anti-Parkinson's pharmaceutical agent rasagiline (51) was achieved using the Rh2(S-TCPTAD)4 catalyst.82 A number of efficient transformations have been achieved at benzylic positions, but broad application of this chemistry is still relatively limited.

Figure 12. a) In-situ generation of metal nitrenoid precursor.

Figure 12

The bridged, achiral rhodium catalyst Rh2(esp)2, developed by Du Bois specifically for nitrenoid reactions has demonstrated remarkable efficiency in both intra- and intermolecular reactions with catalyst loadings as low as 2 mol% (ref 84), b) Exceptionally high diastereoselectivity can be achieved in intermolecular C–H amination reactions when a “matched” reaction is carried out using a chiral sulfonamide as the nitrene precursor and a chiral rhodium catalyst (ref 87), c) The anti-Parkinson's agent rasagiline was synthesized in three steps in high enantiomeric excess using the chiral catalyst Rh2(S-TCPTAD)4 (ref 82).

Future Directions

C–H functionalizations by means of metal carbenoids and metal nitrenoids are rapidly becoming very general strategic reactions for the synthesis of natural products and pharmaceutical targets. The intramolecular C–H insertion of metal carbenoids is now a well-established transformation, while the corresponding intramolecular C–H amination has, in the last few years, been shown to be applicable to the synthesis of highly complex natural product targets. The recognition that donor/acceptor functionalized carbenoids are highly selective intermediates has opened up enantioselective intermolecular C–H insertion as a powerful transformation. Enantioselective intermolecular C–H amination is also developing well and is likely to see broad synthetic application. During the next few years this field is likely to undergo rapid expansion as improved chiral catalysts and even more selective reagents are developed. It has already been shown that these reactions can be considered as complementary to some of the classic reactions of organic synthesis and this will be further underscored as additional ingenious applications of this chemistry to total synthesis are described. As the synthetic utility of C–H functionalization becomes more fully appreciated, its application as an enabling technology for drug discovery and synthesis will become a common practice.

Acknowledgement

The research conducted in the Davies laboratories was supported by the National Institutes of Health (DA06301, DA15225 and GM080337) and the National Science Foundation (CHE-0350536).

Footnotes

Disclosure. In addition to HMLD's academic duties, he is co-owner of Dirhodium Technologies, LLC, a manufacturer of chiral dirhodium catalysts.

References

  • 1.IMS Health Reports Global Pharmaceutical Market Grew 7.0 Percent in 2006 to $643Billion. 2007 http://www.imshealth.com/ims/portal/front/articleC/0,2777,6599_366 5_80560241,00.html.
  • 2.Lipinski C, Hopkins A. Navigating chemical space for biology and medicine. Nature. 2004;432:855–861. doi: 10.1038/nature03193. [DOI] [PubMed] [Google Scholar]
  • 3.King AO, Yasuda N. Palladium-Catalyzed Cross-Coupling Reactions in the Synthesis of Pharmaceuticals. Topics in Organometallic Chemistry. 2004;6:205–245. [Google Scholar]
  • 4.Nicolaou KC, et al. Synthesis of epothilones A and B in solid and solution phase. Nature. 1997;387:268–272. doi: 10.1038/387268a0. [DOI] [PubMed] [Google Scholar]
  • 5.Crabtree RH. A catalytic knight's move. Nature. 2006;441:165–166. doi: 10.1038/441165a. [DOI] [PubMed] [Google Scholar]
  • 6.Grubbs RH. Handbook of Metathesis. Wiley-VCH; New York: 2003. [Google Scholar]
  • 7.Waltz KM, Hartwig JF. Selective Functionalization of Alkanes by Transition-Metal Boryl Complexes. Science. 1997;277:211–213. [Google Scholar]
  • 8.Saaby S, Bayon P, Aburel PS, Jorgensen KA. Optically Active Aromatic and Heteroaromatic α-Amino Acids by a One-Pot Catalytic Enantioselective Addition of Aromatic and Heteroaromatic C–H Bonds to α-Imino Esters. J. Org. Chem. 2002;67:4352–4361. doi: 10.1021/jo0256787. [DOI] [PubMed] [Google Scholar]
  • 9.Bergman RG. Organometallic chemistry: C–H activation. Nature. 2007;446:391–393. doi: 10.1038/446391a. [DOI] [PubMed] [Google Scholar]
  • 10.Arndtsen BA, Bergman RG, Mobley TA, Peterson TH. Selective Intermolecular Carbon-Hydrogen Bond Activation by Synthetic Metal Complexes in Homogeneous Solution. Acc. Chem. Res. 1995;28:154–162. [Google Scholar]
  • 11.Dyker G. Transition Metal Catalyzed Coupling Reactions under C–H Activation. Angew. Chem., Int. Ed. Engl. 1999;38:1698–1712. doi: 10.1002/(SICI)1521-3773(19990614)38:12<1698::AID-ANIE1698>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  • 12.Shilov AE, Shul'pin GB. Activation of C–H Bonds by Metal Complexes. Chem. Rev. 1997;97:2879–2932. doi: 10.1021/cr9411886. [DOI] [PubMed] [Google Scholar]
  • 13.Labinger JA, Bercaw JE. Understanding and exploiting C–H bond activation. Nature. 2002;417:507–514. doi: 10.1038/417507a. [DOI] [PubMed] [Google Scholar]
  • 14.Dick AR, Sanford MS. Transition metal catalyzed oxidative functionalization of carbon-hydrogen bonds. Tetrahedron. 2006;62:2439–2463. [Google Scholar]
  • 15.Godula K, Sames D. C–H Bond Functionalization in Complex Organic Synthesis. Science. 2006;312:67–72. doi: 10.1126/science.1114731. [DOI] [PubMed] [Google Scholar]
  • 16.Dyker G, editor. Handbook of C–H Transformations. Vol. 1 & 2. Wiley-VCH; Weinheim: 2005. [Google Scholar]
  • 17.Yu J-Q, Giri R, Chen X. Sigma-Chelation-directed C–H functionalizations using Pd(II) and Cu(II) catalysts: regioselectivity, stereoselectivity and catalytic turnover. Org. Biomol. Chem. 2006;4:4041–4047. doi: 10.1039/b611094k. [DOI] [PubMed] [Google Scholar]
  • 18.Davies HML, Beckwith REJ. Enantioselective C–H Activation by Means of Metal-Carbenoid-Induced C–H Insertion. Chem. Rev. 2003;103:2861–2903. doi: 10.1021/cr0200217. [DOI] [PubMed] [Google Scholar]
  • 19.Espino CG, DuBois J. Modern Rhodium-Catalyzed Organic Reactions. Wiley-VCH; Weinheim: 2005. [Google Scholar]
  • 20.Davies HML. Recent Advances in Catalytic Enantioselective Intermolecular C–H Functionalization. Angew. Chem., Int. Ed. Engl. 2006;45:6422–6425. doi: 10.1002/anie.200601814. [DOI] [PubMed] [Google Scholar]
  • 21.Doyle MP, McKervey M, Ye T. Modern Catalytic Methods for Organic Synthesis with Diazo Compounds: From Cyclopropanes to Ylides. Wiley; New York: 1998. [Google Scholar]
  • 22.Ye T, McKervey MA. Organic Synthesis with α-Diazocarbonyl Compounds. Chem. Rev. 1994;94:1091–1160. doi: 10.1021/acs.chemrev.5b00121. [DOI] [PubMed] [Google Scholar]
  • 23.Doyle MP, Forbes DC. Recent Advances in Asymmetric Catalytic Metal Carbene Transformations. Chem. Rev. 1998;98:911–935. doi: 10.1021/cr940066a. [DOI] [PubMed] [Google Scholar]
  • 24.Doyle MP, Hu W. Enantioselective Carbon-Hydrogen Insertion is an Effective and Efficient Methodology for the Synthesis of (R)-(−)-Baclofen. Chirality. 2002;14:169–172. doi: 10.1002/chir.10060. [DOI] [PubMed] [Google Scholar]
  • 25.Anada M, Mita O, Watanabe H, Kitagaki S, Hashimoto S. Catalytic Enantioselective Synthesis of the Phosphodiesterase Type IV Inhibitor (R)-(−)-Rolipram via Intramolecular C–H Insertion Process. Synlett. 1999:1775–1777. [Google Scholar]
  • 26.Demonceau A, Noels AF, Hubert AJ, Teyssie P. Transition metal-catalyzed reactions of diazo esters. Insertion into carbon-hydrogen bonds of paraffins catalyzed by bulky rhodium(II) carboxylates: enhanced attack on primary carbon-hydrogen bonds. Bull. Soc. Chim. Belg. 1984;93:945–948. [Google Scholar]
  • 27.Wee AGH, Yu Q. Rh(II)-Catalyzed Reaction of Some α', α'- and β'-Branched-O-Alkyl α-(Alkoxycarbonyl)-α-diazoacetates. J. Org. Chem. 1997;62:3324–3331. doi: 10.1021/jo961484d. [DOI] [PubMed] [Google Scholar]
  • 28.Wang J, Liang F, Chen B. Investigation of Electronic Effects of Rh(II)-Mediated α-Methyl-Substituted Carbenoid Intramolecular C–H Insertion. J. Org. Chem. 1998;63:8589–8594. [Google Scholar]
  • 29.Davies HML, Antoulinakis EG. Recent progress in asymmetric intermolecular C–H activation by rhodium carbenoid intermediates. J. Organomet. Chem. 2001;617–618:47–55. [Google Scholar]
  • 30.Diaz-Requejo MM, Belderrain TR, Nicasio MC, Trofimenko S, Perez PJ. Intermolecular Copper-Catalyzed Carbon-Hydrogen Bond Activation via Carbene Insertion. J. Am. Chem. Soc. 2002;124:896–897. doi: 10.1021/ja016798j. [DOI] [PubMed] [Google Scholar]
  • 31.Urbano J, et al. Functionalization of Primary Carbon-Hydrogen Bonds of Alkanes by Carbene Insertion with a Silver-Based Catalyst. Organometallics. 2005;24:1528–1532. [Google Scholar]
  • 32.Davies HML. Catalytic asymmetric C–H activation of sp3 hybridized C–H bonds by means of carbenoid C–H insertions: applications in organic synthesis. J. Molec. Catal. A. 2002;189:125–135. [Google Scholar]
  • 33.Davies HML, Hansen T, Churchill MR. Catalytic Asymmetric C–H Activation of Alkanes and Tetrahydrofuran. J. Am. Chem. Soc. 2000;122:3063–3070. [Google Scholar]
  • 34.Keating GM, Figgitt DP. Dexmethylphenidate. Drugs. 2002;62:1899–1904. doi: 10.2165/00003495-200262130-00009. [DOI] [PubMed] [Google Scholar]
  • 35.Panizzon L. La preparazione di piridil-e piperidil-arilacetonitrili e di alcuni prodotti di trasformazione (Parte 1a) Helv. Chim. Acta. 1944;27:1748–1756. [Google Scholar]
  • 36.Deutsch HM, Shi Q, Gruszecka-Kowalik E, Schweri MM. Synthesis and Pharmacology of Potential Cocaine Antagonists. 2. Structure-Activity Relationship Studies of Aromatic Ring-Substituted Methylphenidate Analogs. J. Med. Chem. 1996;39:1201–1209. doi: 10.1021/jm950697c. [DOI] [PubMed] [Google Scholar]
  • 37.Axten JM, Krim L, Kung HF, Winkler JD. A Stereoselective Synthesis of dl-threo-Methylphenidate: Preparation and Biological Evaluation of Novel Analogues. J. Org. Chem. 1998;63:9628–9629. [Google Scholar]
  • 38.Davies HML, Hansen T, Hopper DW, Panaro SA. Highly Regio-, Diastereo-, and Enantioselective C–H Insertions of Methyl Aryldiazoacetates into Cyclic N-Boc-Protected Amines. Asymmetric Synthesis of Novel C2-Symmetric Amines and threo-Methylphenidate. J. Am. Chem. Soc. 1999;121:6509–6510. [Google Scholar]
  • 39.Davies HML, Panaro SA. Novel dirhodium tetraprolinate catalysts containing bridging prolinate ligands for asymmetric carbenoid reactions. Tetrahedron Lett. 1999;40:5287–5290. [Google Scholar]
  • 40.Davies HML, Ren P. Catalytic Asymmetric C–H Activation of Silyl Enol Ethers as an Equivalent of an Asymmetric Michael Reaction. J. Am. Chem. Soc. 2001;123:2070–2071. doi: 10.1021/ja0035607. [DOI] [PubMed] [Google Scholar]
  • 41.Davies HML, Ren P, Jin Q. Catalytic Asymmetric Allylic C–H Activation as a Surrogate of the Asymmetric Claisen Rearrangement. Org. Lett. 2001;3:3587–3590. doi: 10.1021/ol0167255. [DOI] [PubMed] [Google Scholar]
  • 42.Davies HML, Venkataramani C. Catalytic Enantioselective Synthesis of β2-Amino Acids. Angew. Chem., Int. Ed. Engl. 2002;41:2197–2199. [PubMed] [Google Scholar]
  • 43.Davies HML, Venkataramani C, Hansen T, Hopper DW. New Strategic Reactions for Organic Synthesis: Catalytic Asymmetric C–H Activation alpha to Nitrogen as a Surrogate for the Mannich Reaction. J. Am. Chem. Soc. 2003;125:6462–6468. doi: 10.1021/ja0290072. [DOI] [PubMed] [Google Scholar]
  • 44.Davies HML, Beckwith REJ, Antoulinakis EG, Jin Q. New Strategic Reactions for Organic Synthesis: Catalytic Asymmetric C–H Activation α to Oxygen as a Surrogate to the Aldol Reaction. J. Org. Chem. 2003;68:6126–6132. doi: 10.1021/jo034533c. [DOI] [PubMed] [Google Scholar]
  • 45.Davies HML, Yang J, Nikolai J. Asymmetric C–H insertion of Rh(II) stabilized carbenoids into acetals: A C–H activation protocol as a Claisen condensation equivalent. J. Organomet. Chem. 2005;690:6111–6124. [Google Scholar]
  • 46.Davies HML, Antoulinakis EG. Asymmetric Catalytic C–H Activation Applied to the Synthesis of Syn-Aldol Products. Org. Lett. 2000;2:4153–4156. doi: 10.1021/ol006671j. [DOI] [PubMed] [Google Scholar]
  • 47.Doyle MP, et al. Electronic and Steric Control in Carbon-Hydrogen Insertion Reactions of Diazoacetoacetates Catalyzed by Dirhodium(II) Carboxylates and Carboxamides. J. Am. Chem. Soc. 1993;115:958–964. [Google Scholar]
  • 48.Wang P, Adams J. Model Studies of the Stereoelectronic Effect in Rh(II) Mediated Carbenoid C–H Insertion Reactions. J. Am. Chem. Soc. 1994;116:3296–3305. [Google Scholar]
  • 49.Davies HML, Jin Q. Double C–H Activation Strategy for the Asymmetric Synthesis of C2-Symmetric Anilines. Org. Lett. 2004;6:1769–1772. doi: 10.1021/ol0495467. [DOI] [PubMed] [Google Scholar]
  • 50.Davies HML, Ni A. Enantioselective synthesis of β-amino esters and its application to the synthesis of the enantiomers of the antidepressant Venlafaxine. Chem. Commun. 2006:3110–3112. doi: 10.1039/b605047f. [DOI] [PubMed] [Google Scholar]
  • 51.Davies HML, Stafford DG, Hansen T. Catalytic Asymmetric Synthesis of Diarylacetates and 4,4-Diarylbutanoates. A Formal Asymmetric Synthesis of (+)-Sertraline. Org. Lett. 1999;1:233–236. doi: 10.1021/ol9903943. [DOI] [PubMed] [Google Scholar]
  • 52.Davies HML, Jin Q. Highly Diastereoselective and Enantioselective C–H Functionalization of 1,2-Dihydronaphthalenes: A Combined C–H Activation/Cope Rearrangement Followed by a Retro-Cope Rearrangement. J. Am. Chem. Soc. 2004;126:10862–10863. doi: 10.1021/ja047185k. [DOI] [PubMed] [Google Scholar]
  • 53.Davies HML, Jin Q. Catalytic asymmetric reactions for organic synthesis: The combined C–H activation/Cope rearrangement. Proc. Natl. Acad. Sci. U. S. A. 2004;101:5472–5475. doi: 10.1073/pnas.0307556101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Davies HML, Jin Q. Enantioselective Double C–H Activation of Dihydronaphthalenes. Org. Lett. 2005;7:2293–2296. doi: 10.1021/ol050018k. [DOI] [PubMed] [Google Scholar]
  • 55.Davies HML, Yang J, Manning JR. Direct synthesis of methyl 2-diazo-4-aryl-3-butenoates and their application to the enantioselective synthesis of 4-aryl-4-(1-naphthyl)-2-butenoates. Tetrahedron Asymmetry. 2006;17:665–673. [Google Scholar]
  • 56.Davies HML, Manning JR. C–H Activation as a Strategic Reaction: Enantioselective Synthesis of 4-Substituted Indoles. J. Am. Chem. Soc. 2006;128:1060–1061. doi: 10.1021/ja057768+. [DOI] [PubMed] [Google Scholar]
  • 57.Kleeman A, Engel J, Kutscher B, Reichert D. Pharmaceutical Substances. 4th ed. Thieme; New York: 2001. [Google Scholar]
  • 58.Austin JF, MacMillan DWC. Enantioselective Organocatalytic Indole Alkylations. Design of a New and Highly Effective Chiral Amine for Iminium Catalysis. J. Am. Chem. Soc. 2002;124:1172–1173. doi: 10.1021/ja017255c. [DOI] [PubMed] [Google Scholar]
  • 59.Ferreira EM, Stoltz BM. Catalytic C–H Bond Functionalization with Palladium(II): Aerobic Oxidative Annulations of Indoles. J. Am. Chem. Soc. 2003;125:9578–9579. doi: 10.1021/ja035054y. [DOI] [PubMed] [Google Scholar]
  • 60.Evans DA, Scheidt KA, Fandrick KR, Lam HW, Wu J. Enantioselective Indole Friedel-Crafts Alkylations Catalyzed by Bis(oxazolinyl)pyridine-Scandium(III) Triflate Complexes. J. Am. Chem. Soc. 2003;125:10780–10781. doi: 10.1021/ja036985c. [DOI] [PubMed] [Google Scholar]
  • 61.Heckrodt TJ, Mulzer J. Marine Natural Products from Pseudopterogorgia elisabethae: Structures, Biosynthesis, Pharmacology, and Total Synthesis. Top. Curr. Chem. 2005;244:1–41. [Google Scholar]
  • 62.Nicolaou KC, Vassilikogiannakis G, Magerlein W, Kranich R. Total Synthesis of Colombiasin A. Angew. Chem., Int. Ed. Engl. 2001;40:2482–2486. doi: 10.1002/1521-3773(20010702)40:13<2482::AID-ANIE2482>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  • 63.Kim AI, Rychnovsky SD. Unified Strategy for the Synthesis of (−)-Elisapterosin B and (−)-Colombiasin A. Angew. Chem., Int. Ed. Engl. 2003;42:1267–1270. doi: 10.1002/anie.200390325. [DOI] [PubMed] [Google Scholar]
  • 64.Harrowven DC, Pascoe DD, Demurtas D, Bourne HO. Total Synthesis of (−)-Colombiasin A and (−)-Elisapterosin B. Angew. Chem., Int. Ed. Engl. 2005;44:1221–1222. doi: 10.1002/anie.200462268. [DOI] [PubMed] [Google Scholar]
  • 65.Boezio AA, Jarvo ER, Lawrence BM, Jacobsen EN. Efficient Total Syntheses of (−)-Colombiasin A and (−)-Elisapterosin B: Application of the Cr-Catalyzed Asymmetric Quinone Diels-Alder Reaction. Angew. Chem., Int. Ed. Engl. 2005;44:6046–6050. doi: 10.1002/anie.200502178. [DOI] [PubMed] [Google Scholar]
  • 66.Waizumi N, Stankovic AR, Rawal VH. A General Strategy to Elisabethane Diterpenes: Stereocontrolled Synthesis of Elisapterosin B via Oxidative Cyclization of an Elisabethin Precursor. J. Am. Chem. Soc. 2003;125:13022–13023. doi: 10.1021/ja035898h. [DOI] [PubMed] [Google Scholar]
  • 67.Cesati I, R. R., de Armas J, Hoveyda AH. Enantioselective Total Synthesis of Erogorgiaene: Applications of Asymmetric Cu-Catalyzed Conjugate Additions of Alkylzincs to Acyclic Enones. J. Am. Chem. Soc. 2004;126:96–101. doi: 10.1021/ja0305407. [DOI] [PubMed] [Google Scholar]
  • 68.Davies HML, Bruzinski PR, Lake DH, Kong N, Fall MJ. Asymmetric Cyclopropanations by Rhodium(II) N-(Arylsulfonyl)prolinate Catalyzed Decomposition of Vinyldiazomethanes in the Presence of Alkenes. Practical Enantioselective Synthesis of the Four Stereoisomers of 2-Phenylcyclopropan-1-amino Acid. J. Am. Chem. Soc. 1996;118:6897–6907. [Google Scholar]
  • 69.Davies HML, Walji AM. Direct Synthesis of (+)-Erogorgiaene through a Kinetic Enantiodifferentiating Step. Angew. Chem., Int. Ed. Engl. 2005;44:1733–1735. doi: 10.1002/anie.200462227. [DOI] [PubMed] [Google Scholar]
  • 70.Davies HML, Dai X, Long MS. Combined C–H Activation/Cope Rearrangement as a Strategic Reaction in Organic Synthesis: Total Synthesis of (−)-Colombiasin A and (−)-Elisapterosin B. J. Am. Chem. Soc. 2006;128:2485–2490. doi: 10.1021/ja056877l. [DOI] [PubMed] [Google Scholar]
  • 71.Davies HML, Dai X. Application of the combined C–H activation/Cope rearrangement as a key step in the total syntheses of the assigned structure of (+)-elisabethadione and a (+)-p-benzoquinone natural product. Tetrahedron. 2006;62:10477–10484. [Google Scholar]
  • 72.Muller P, Fruit C. Enantioselective Catalytic Aziridinations and Asymmetric Nitrene Insertions into CH Bonds. Chem. Rev. 2003;103:2905–2919. doi: 10.1021/cr020043t. [DOI] [PubMed] [Google Scholar]
  • 73.Davies HML, Long MS. Recent Advances in Catalytic Intramolecular C–H Aminations. Angew. Chem., Int. Ed. Engl. 2005;44:3518–3520. doi: 10.1002/anie.200500554. [DOI] [PubMed] [Google Scholar]
  • 74.Wehn PM, DuBois J. Enantioselective Synthesis of the Bromopyrrole Alkaloids Manzacidin A and C by Stereospecific C–H Bond Oxidation. J. Am. Chem. Soc. 2002;124:12950–12951. doi: 10.1021/ja028139s. [DOI] [PubMed] [Google Scholar]
  • 75.Fleming JJ, DuBois J. A Synthesis of (+)-Saxitoxin. J. Am. Chem. Soc. 2006;128:3926–3927. doi: 10.1021/ja0608545. [DOI] [PubMed] [Google Scholar]
  • 76.Hinman A, DuBois J. A Stereoselective Synthesis of (−)-Tetrodotoxin. J. Am. Chem. Soc. 2003;125:11510–11511. doi: 10.1021/ja0368305. [DOI] [PubMed] [Google Scholar]
  • 77.Dauban P, Dodd RH. Iminoiodanes and C–N Bond Formation in Organic Synthesis. Synlett. 2003:1571–1586. [Google Scholar]
  • 78.Yu X-Q, Huang J-S, Zhou X-G, Che C-M. Amidation of Saturated C–H Bonds Catalyzed by Electron-Deficient Ruthenium and Manganese Porphyrins. A Highly Catalytic Nitrogen Atom Transfer Process. Org. Lett. 2000;2:2233–2236. doi: 10.1021/ol000107r. [DOI] [PubMed] [Google Scholar]
  • 79.Espino CG, DuBois J. A Rh-Catalyzed C–H Insertion Reaction for the Oxidative Conversion of Carbamates to Oxazolidinones. Angew. Chem., Int. Ed. Engl. 2001;40:598–600. doi: 10.1002/1521-3773(20010202)40:3<598::AID-ANIE598>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  • 80.Lebel H, Huard K, Lectard S. N-Tosyloxycarbamates as a Source of Metal Nitrenes: Rhodium-Catalyzed C–H Insertion and Aziridination Reactions. J. Am. Chem. Soc. 2005;127:14198–14199. doi: 10.1021/ja0552850. [DOI] [PubMed] [Google Scholar]
  • 81.Lebel H, Huard K. De Novo Synthesis of Troc-Protected Amines: Intermolecular Rhodium-Catalyzed C–H Amination with N-Tosyloxycarbamates. Org. Lett. 2007;9:639–642. doi: 10.1021/ol062953t. [DOI] [PubMed] [Google Scholar]
  • 82.Reddy RP, Davies HML. Dirhodium Tetracarboxylates Derived from Adamantylglycine as Chiral Catalysts for Enantioselective C–H Aminations. Org. Lett. 2006;8:5013–5016. doi: 10.1021/ol061742l. [DOI] [PubMed] [Google Scholar]
  • 83.Espino CG, Fiori KW, Kim M, DuBois J. Expanding the Scope of C–H Amination through Catalyst Design. J. Am. Chem. Soc. 2004;1267:15378–15379. doi: 10.1021/ja0446294. [DOI] [PubMed] [Google Scholar]
  • 84.Fiori KW, DuBois J. Catalytic Intermolecular Amination of C–H Bonds: Method Development and Mechanistic Insights. J. Am. Chem. Soc. 2007;129:562–568. doi: 10.1021/ja0650450. [DOI] [PubMed] [Google Scholar]
  • 85.Kim M, Mulcahy JV, Espino CG, DuBois J. Expanding the Substrate Scope for C–H Amination Reactions: Oxidative Cyclization of Urea and Guanidine Derivatives. Org. Lett. 2006;8:1073–1076. doi: 10.1021/ol052920y. [DOI] [PubMed] [Google Scholar]
  • 86.Yamawaki M, Tsutsui H, Kitagaki S, Anada M, Hashimoto S. Dirhodium(II) tetrakis[N-tetrachlorophthaloyl-(S)-tert-leucinate]: a new chiral Rh(II) catalyst for enantioselective amidation of C–H bonds. Tetrahedron Lett. 2002;43:9561–9564. [Google Scholar]
  • 87.Liang C, et al. Efficient Diastereoselective Intermolecular Rhodium-Catalyzed C–H Amination. Angew. Chem., Int. Ed. Engl. 2006;45:4641–4644. doi: 10.1002/anie.200601248. [DOI] [PubMed] [Google Scholar]

RESOURCES